Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Joint strategy to benefit human and animal health
Syringe
The document under consultation outlines joint key priorities for the network.

Draft document outlines priorities for next five years

The European Medicines Agency (EMA) and Heads of Medicines Agencies (HMA) have released the 'EU Medicines Agencies Network Strategy to 2020'.

The document focuses on areas where collaboration within the network can make a difference to human and animal health in Europe in the next five years.

It is presented, for the first time, as a single strategy for the entire network - reflecting the need for a coordinated approach.

Arranged under four key themes, the strategy focusses on:

  • Human health
  • Animal and human health in relation to veterinary medicines,
  • Optimising the operation of the network
  • The global regulatory environment
It also includes a high level strategy to achieve these priorities.  

EMA and HMA say that the need to further strengthen the collaboration between the members of the network and work together towards achieving agreed goals has become more urgent in recent years.

"Europe faces the global threat of antibiotic resistance, and needs to be prepared for emerging epidemics," a spokesperson said.  "At the same time, the healthcare needs of patients in Europe are changing.  

"Advancements in science and medicine mean that new and more complex medicines are being developed, which may bring opportunities for personalised medicines and more treatments for rare diseases. Patients also require timely access to new, beneficial and safe medicines.

"The globalisation of the pharmaceutical industry means that greater collaboration with regulators beyond the European Union (EU) is essential to assure the supply of safe, effective and good quality medicines for humans and animals."

To view the Strategy visit www.ema.europa.eu. Stakeholders are invited to send their comments to EUnetworkstrategy@ema.europa.eu by 30 June 2015.

Become a member or log in to add this story to your CPD history

RCVS announces 1CPD app update

News Story 1
 The RCVS has announced a new version of its 1CPD mobile app, with enhanced features for veterinary surgeons and veterinary nurses to record their continuing professional development.

The mobile app includes a new 'what would you like to do?' shortcut for frequent tasks, a notification badge, and the ability to scan a QR code from the home screen to easily record an activity.

Users will be prompted to update the app from the App Store or Google Play the next time they log in. For more information, visit RCVS.org.uk 

Click here for more...
News Shorts
Nominations open for RCVS and VN Council elections

The nomination period for the 2026 RCVS Council and VN Council elections is now open, with three veterinary surgeon seats and two veterinary nurse seats available.

Prospective candidates can download an information pack and nomination form from the RCVS website. Individuals can nominate themselves for the elections, with the results to be announced in the spring.

Clare Paget, the recently appointed RCVS Registrar and elections returning officer, said: "If you want to play your part in influencing and moulding how the professions are regulated, and making key decisions on matters of great importance to your peers, the public and animal health and welfare, please consider standing for RCVS Council or VN Council next year."

Nominations close at 5pm on Saturday, 31 January 2026.